EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Single‐Nuclei RNA Sequencing Shows the Engagement of PPAR‐Delta Target Genes Primarily in Hepatocytes and Cholangiocytes by the Selective PPAR‐Delta Agonist Seladelpar

Tomoo Yamazaki iD, Yongqiang Yang, David Schöler iD, Yoshimi Yukawa-Muto, Tetsuya Kouno, Aenne Harberts iD, Sadatsugu Sakane iD, Linton Freund, Cynthia L Hsu iD, Thomas C Whisenant iD, Sara Brin Rosenthal iD, Tatiana Kisseleva und 2 weitere

PPAR Research · 2025-01 · 2025 (1)

DOI: 10.1155/ppar/2935230 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PPAR Research, online erschienen am 23.10.2025. Verfasst von Tomoo Yamazaki und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of California San Diego, La Jolla, California, USA. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: BLRD VA, NIAAA NIH HHS, NIDDK NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims The selective peroxisome proliferator–activated receptor delta (PPARD) agonist seladelpar reduces liver injury and modulates bile acid metabolism in preclinical models. Seladelpar was recently approved for the secondary treatment of primary biliary cholangitis (PBC). Despite its beneficial effects for liver diseases, the target cells of seladelpar on a single‐cell level remain unknown. This study is aimed at investigating the effect of seladelpar on single liver cells. Methods and Results CD‐1 mice were gavaged with vehicle or seladelpar (10 mg/kg body weight), and the liver was harvested 6 h later. Single‐nuclei RNA sequencing (snRNA‐seq) analysis showed the engagement of PPARD target genes primarily in hepatocytes and cholangiocytes by seladelpar. The top two upregulated genes, Ehhadh and Cyp4a14 , are related to fatty acid metabolism and were increased in hepatocytes, cholangiocytes, and Kupffer cells. Abcb4 , an important canalicular transporter with hepatoprotective effects, was significantly upregulated in hepatocytes. We confirmed upregulated Abcb4 gene expression in seladelpar‐treated primary mouse hepatocytes isolated from C57BL/6 mice. We further incubated nonparenchymal liver cells with seladelpar. Although there was a significant increase in the PPARD‐responsive genes Pdk4 and Angptl4 in cholangiocytes, Kupffer cells, and hepatic stellate cells, seladelpar did not exert specific liver‐protective effects in these cell types. Conclusion The selective PPARD agonist seladelpar induced PPARD‐responsive genes primarily in hepatocytes and cholangiocytes. Seladelpar upregulated Abcb4 in hepatocytes, which might contribute to its beneficial effects in cholestatic liver disorders.

Schlagwörter

Stichwörter der Autor:innen

RNA sequencingliver nonparenchymal cellsmetabolic dysfunction–associated steatohepatitisperoxisome proliferator–activated receptorsprimary biliary cholangitis

Autor:innen und Institutionen

  • Department of Medicine, University of California San Diego, La Jolla, California, USA.
  • Department of Medicine, Division of Gastroenterology and Hepatology, Shinshu University, Matsumoto, Japan.
  • Department of Surgery, University of California San Diego, San Diego, California, USA.
  • Department of Surgery, University of California San Diego, La Jolla, California, USA.
  • CymaBay Therapeutics, Fremont, California, USA.
  • Department of Medicine, VA San Diego Healthcare System, San Diego, California, USA.

ORCID-Profile: Tomoo Yamazaki, David Schöler, Aenne Harberts, Sadatsugu Sakane, Cynthia L Hsu, Thomas C Whisenant, Sara Brin Rosenthal, Edward E Cable, Bernd Schnabl

Förderung

  • BLRD VA
  • NIAAA NIH HHS
  • NIDDK NIH HHS
  • Deutsche Forschungsgemeinschaft
  • American Association for the Study of Liver Diseases
  • National Institute on Alcohol Abuse and Alcoholism
  • National Institutes of Health

Zitieren

APA

Yamazaki, T., Yang, Y., Schöler, D., Yukawa-Muto, Y., Kouno, T., Harberts, A., Sakane, S., Freund, L., Hsu, C. L., Whisenant, T. C., Rosenthal, S. B., Kisseleva, T., Cable, E. E., & Schnabl, B. (2025). Single‐Nuclei RNA Sequencing Shows the Engagement of PPAR‐Delta Target Genes Primarily in Hepatocytes and Cholangiocytes by the Selective PPAR‐Delta Agonist Seladelpar. PPAR Research, 2025(1). https://doi.org/10.1155/ppar/2935230

Vancouver

Yamazaki T, Yang Y, Schöler D, Yukawa-Muto Y, Kouno T, Harberts A, et al. Single‐Nuclei RNA Sequencing Shows the Engagement of PPAR‐Delta Target Genes Primarily in Hepatocytes and Cholangiocytes by the Selective PPAR‐Delta Agonist Seladelpar. PPAR Research. 2025;2025(1). doi:10.1155/ppar/2935230

BibTeX
@article{Yamazaki2025,
  author = {Yamazaki, Tomoo and Yang, Yongqiang and Schöler, David and Yukawa-Muto, Yoshimi and Kouno, Tetsuya and Harberts, Aenne and Sakane, Sadatsugu and Freund, Linton and Hsu, Cynthia L and Whisenant, Thomas C and Rosenthal, Sara Brin and Kisseleva, Tatiana and Cable, Edward E and Schnabl, Bernd},
  title = {Single‐Nuclei RNA Sequencing Shows the Engagement of PPAR‐Delta Target Genes Primarily in Hepatocytes and Cholangiocytes by the Selective PPAR‐Delta Agonist Seladelpar},
  journal = {PPAR Research},
  year = {2025},
  volume = {2025},
  number = {1},
  doi = {10.1155/ppar/2935230}
}
Kostenlos starten →